Format

Send to

Choose Destination
Case Rep Ophthalmol. 2016 Jan 8;7(1):1-8. doi: 10.1159/000443322. eCollection 2016 Jan-Apr.

Pars Plana Vitrectomy Combined with Internal Limiting Membrane Peeling to Treat Persistent Macular Edema after Anti-Vascular Endothelial Growth Factor Treatment in Cases of Ischemic Central Retinal Vein Occlusion.

Author information

1
Department of Ophthalmology, Kagawa University Faculty of Medicine, Takamatsu, Okayama, Japan.
2
Department of Ophthalmology, Okayama University, Okayama, Japan.

Abstract

OBJECTIVE:

To evaluate the efficacy of pars plana vitrectomy (PPV) combined with internal limiting membrane (ILM) peeling in cases of ischemic central retinal vein occlusion (CRVO) where macular edema (ME) persisted after anti-vascular endothelial growth factor (anti-VEGF) treatment.

METHODS:

Fifteen eyes with ischemic CRVO-related ME were included in the study. Nine were treated with panretinal photocoagulation after initial examination. Anti-VEGF agents were injected intravitreally. Persistent ME was treated with PPV combined with ILM peeling. During surgery, laser photocoagulation was further applied to the non-perfused area.

RESULTS:

Mean retinal thickness gradually decreased after surgery (p = 0.024 at 6 months), although visual acuity did not improve significantly during the follow-up period (14.7 ± 11.6 months). Neovascular glaucoma subsequently developed in three cases and a trabeculectomy was performed in one case.

CONCLUSION:

In eyes with ischemic CRVO, PPV combined with ILM peeling contributed to a reduction in persistent ME. However, there was no significant improvement in visual acuity.

KEYWORDS:

Anti-vascular endothelial growth factor; Central retinal vein occlusion; Internal limiting membrane peeling; Macular edema; Pars plana vitrectomy

Supplemental Content

Full text links

Icon for S. Karger AG, Basel, Switzerland Icon for PubMed Central
Loading ...
Support Center